{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:48:35Z","timestamp":1769633315856,"version":"3.49.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8,1]]},"abstract":"<jats:p>Surfactant therapy has become an effective standard therapy for infants with respiratory distress syndrome (RDS). The first dose may be given either as prophylaxis immediately after delivery, or as rescue after an infant has developed RDS. Second and subsequent doses are currently recommended by the manufacturers to be administered at minimal levels of respiratory support.<\/jats:p><jats:p>Purpose.\u2003This study compared the relative efficacy of administering second and subsequent doses of Infasurf surfactant at a low threshold (Fio2 &amp;gt;30%, still requiring endotracheal intubation) versus a high threshold (Fio2 &amp;gt;40%, mean airway pressure &amp;gt;7 cm H2O) of respiratory support.<\/jats:p><jats:p>Methods.\u2003A total of 2484 neonates received a first dose of surfactant; 1267 reached conventional retreatment criteria and were randomized to be retreated according to low- or high-threshold criteria. They were then retreated at a minimum of 6-hour intervals each time they reached their assigned threshold until receiving a maximum of 4 total doses. Subjects were stratified by whether they received their first dose by prophylaxis or rescue and by whether their lung disease was considered complicated (evidence of perinatal compromise or sepsis) or uncomplicated.<\/jats:p><jats:p>Results.\u2003Among the patients randomized, 33% of prophylaxis and 23% of rescue subjects met criteria for the complicated stratum. Although infants allocated to the high-threshold strategy were receiving slightly more oxygen at 72 hours, there was no difference in the number receiving mechanical ventilation at 72 hours or in the secondary respiratory outcomes (requirement for supplemental oxygen or mechanical ventilation at 28 days, supplemental oxygen at 36 weeks' postconceptional age, inspired oxygen concentration &amp;gt;60% at any time). However, there was a significantly higher mortality for infants with complicated RDS who had received retreatment according to the high-threshold strategy.<\/jats:p><jats:p>Conclusions.\u2003We conclude that equal efficacy can be realized by delaying surfactant retreatment of infants with uncomplicated RDS until they have reached a higher level of respiratory support than is the current standard. We speculate that this would result in a substantial cost-saving from less utilization of drug. Conversely, we believe that infants with complicated RDS should continue to be treated by the low-threshold retreatment strategy, which is currently recommended by the manufacturers of the commercially available surfactants.<\/jats:p>","DOI":"10.1542\/peds.106.2.282","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:50:41Z","timestamp":1092441041000},"page":"282-288","source":"Crossref","is-referenced-by-count":50,"title":["High-Versus Low-Threshold Surfactant Retreatment For Neonatal Respiratory Distress Syndrome"],"prefix":"10.1542","volume":"106","author":[{"given":"John","family":"Kattwinkel","sequence":"first","affiliation":[{"name":"From the University of Virginia, Charlottesville, Virginia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry T.","family":"Bloom","sequence":"additional","affiliation":[{"name":"Wesley Medical Center, Wichita, Kansas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Delmore","sequence":"additional","affiliation":[{"name":"Wesley Medical Center, Wichita, Kansas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Glick","sequence":"additional","affiliation":[{"name":"University of Mississippi, Jackson, Mississippi;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[{"name":"Newark Beth Israel Medical Center, Newark, New Jersey;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Lopez","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Willett","sequence":"additional","affiliation":[{"name":"University of Nebraska, Omaha, Nebraska; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund A.","family":"Egan","sequence":"additional","affiliation":[{"name":"State University of New York, Buffalo, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Conaway","sequence":"additional","affiliation":[{"name":"From the University of Virginia, Charlottesville, Virginia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Patrie","sequence":"additional","affiliation":[{"name":"From the University of Virginia, Charlottesville, Virginia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"2021121003194453300_B1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0034-5687(85)90070-2","article-title":"Leakage of protein in the immature rabbit lung; effect of surfactant replacement.","volume":"61","author":"Robertson","year":"1985","journal-title":"Respir Physiol."},{"key":"2021121003194453300_B2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1152\/jappl.1985.58.2.326","article-title":"Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.","volume":"58","author":"Seeger","year":"1985","journal-title":"J Appl Physiol."},{"key":"2021121003194453300_B3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/ajrccm\/145.5.1005","article-title":"Lung albumin recovery in surfactant-treated preterm ventilated lambs.","volume":"145","author":"Ikegami","year":"1992","journal-title":"Am Rev Respir Dis."},{"key":"2021121003194453300_B4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1164\/ajrccm.152.1.7599809","article-title":"Decreased surfactant dose-response after delayed administration to preterm rabbits.","volume":"152","author":"Seidner","year":"1995","journal-title":"Am J Respir Crit Care Med."},{"key":"2021121003194453300_B5","first-page":"359","article-title":"Bronchiolar epithelial lesions induced in the premature rabbit neonate by short periods of artificial ventilation.","volume":"88","author":"Nilsson","year":"1980","journal-title":"Acta Pathol Microbiol Scand."},{"key":"2021121003194453300_B6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/01902148809064190","article-title":"Sublethal hyperoxic injury to the alveolar epithelium and the pulmonary surfactant system.","volume":"14","author":"Matalon","year":"1988","journal-title":"Exper Lung Res."},{"key":"2021121003194453300_B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1203\/00006450-198506000-00014","article-title":"Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age.","volume":"19","author":"Notter","year":"1985","journal-title":"Pediatr Res."},{"key":"2021121003194453300_B8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.100.1.31","article-title":"Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and pervention of respiratory distress syndrome.","volume":"100","author":"Bloom","year":"1997","journal-title":"Pediatrics."},{"key":"2021121003194453300_B9"},{"key":"2021121003194453300_B10","first-page":"4","article-title":"Surfactant replacement therapy.","volume":"20","author":"Long","year":"1993","journal-title":"Clin Perinatol."},{"key":"2021121003194453300_B11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199103283241301","article-title":"A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.","volume":"324","author":"Kendig","year":"1991","journal-title":"N Engl J Med."},{"key":"2021121003194453300_B12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1542\/peds.92.6.768","article-title":"Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.","volume":"92","author":"Egberts","year":"1993","journal-title":"Pediatrics."},{"key":"2021121003194453300_B13","first-page":"90","article-title":"Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.","volume":"92","author":"Kattwinkel","year":"1993","journal-title":"Pediatrics."},{"key":"2021121003194453300_B14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1651-2227.1995.tb13792.x","article-title":"Porcine surfactant replacement therapy in newborns of 25\u201331 weeks gestation: a randomized, multicenter trial of prophylaxis versus rescue with multiple low doses.","volume":"84","author":"Walti","year":"1995","journal-title":"Acta Paediatr."},{"key":"2021121003194453300_B15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1515\/jpme.1996.24.6.609","article-title":"Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicenter prospective randomized trial.","volume":"24","author":"Bevilacqua","year":"1996","journal-title":"J Perinatal Med."},{"key":"2021121003194453300_B16","doi-asserted-by":"crossref","first-page":"F70","DOI":"10.1136\/fn.77.1.F70","article-title":"Systematic review of prophylactic vs rescue surfactant.","volume":"77","author":"Morley","year":"1997","journal-title":"Arch Dis Child."},{"key":"2021121003194453300_B17","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/0140-6736(92)92557-V","article-title":"Early versus delayed neonatal administration of synthetic surfactant\u2014the judgement of OSIRIS.","volume":"340","author":"The OSIRIS Collaborative Group","year":"1992","journal-title":"Lancet."},{"key":"2021121003194453300_B18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1542\/peds.102.5.1153","article-title":"Early versus late surfactant treatment in preterm infants of 27 to 32 weeks gestational age: a multicenter controlled clinical trial.","volume":"102","author":"Gortner","year":"1998","journal-title":"Pediatrics."},{"key":"2021121003194453300_B19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/ajrccm\/139.2.352","article-title":"Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs.","volume":"139","author":"Jobe","year":"1989","journal-title":"Am Rev Respir Dis."},{"key":"2021121003194453300_B20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1542\/peds.86.4.564","article-title":"Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks gestation with respiratory distress syndrome.","volume":"86","author":"Dunn","year":"1990","journal-title":"Pediatrics."},{"key":"2021121003194453300_B21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1542\/peds.88.1.10","article-title":"Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.","volume":"88","author":"Hoekstra","year":"1991","journal-title":"Pediatrics."},{"key":"2021121003194453300_B22","first-page":"L1","article-title":"Clearance and recycling of pulmonary surfactant.","volume":"259","author":"Wright","year":"1990","journal-title":"Am J Physiol."},{"key":"2021121003194453300_B23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/ajrccm\/145.5.999","article-title":"A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.","volume":"145","author":"Cummings","year":"1992","journal-title":"Am Rev Respir Dis."},{"key":"2021121003194453300_B24","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm\/144.6.1376","article-title":"Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid: correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.","volume":"144","author":"Hallman","year":"1991","journal-title":"Am Rev Respir Dis."},{"key":"2021121003194453300_B25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1203\/00006450-198210000-00007","article-title":"Surfactant supplementation in the preterm rabbit. Effects of applied volume on compliance and survival.","volume":"16","author":"Metcalf","year":"1982","journal-title":"Pediatr Res."},{"key":"2021121003194453300_B26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00441920","article-title":"Effect of supplementary surfactant on the in vivo lung mechanics in the premature rabbit neonate.","volume":"136","author":"Lachmann","year":"1981","journal-title":"Eur J Pediatr."},{"key":"2021121003194453300_B27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1203\/00006450-199211000-00023","article-title":"Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.","volume":"32","author":"Vilstrup","year":"1992","journal-title":"Pediatr Res."},{"key":"2021121003194453300_B28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/ajrccm.154.4.8887586","article-title":"Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome.","volume":"154","author":"Bjorklund","year":"1996","journal-title":"Am J Respir Crit Care Med."},{"key":"2021121003194453300_B29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.93.06070971","article-title":"Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.","volume":"6","author":"Seeger","year":"1993","journal-title":"Eur Respir J."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/2\/282\/841104\/282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/106\/2\/282\/841104\/282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:31:59Z","timestamp":1682746319000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/106\/2\/282\/62933\/High-Versus-Low-Threshold-Surfactant-Retreatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,8,1]]},"published-print":{"date-parts":[[2000,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.106.2.282","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8,1]]}}}